FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 4 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $89,000 | -45.7% | 26,791 | -50.5% | 0.00% | 0.0% |
| Q3 2019 | $164,000 | +397.0% | 54,076 | +715.3% | 0.00% | – |
| Q2 2018 | $33,000 | +230.0% | 6,633 | +290.2% | 0.00% | – |
| Q4 2017 | $10,000 | -84.4% | 1,700 | -87.7% | 0.00% | -100.0% |
| Q2 2017 | $64,000 | +433.3% | 13,791 | +489.1% | 0.00% | – |
| Q1 2017 | $12,000 | – | 2,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 984,734 | $10,094,000 | 5.25% |
| SENZAR ASSET MANAGEMENT, LLC | 707,449 | $7,251,000 | 1.24% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,133,390 | $11,617,000 | 0.88% |
| Ghost Tree Capital, LLC | 250,000 | $2,563,000 | 0.83% |
| Sio Capital Management, LLC | 161,286 | $1,653,000 | 0.82% |
| SPHERA FUNDS MANAGEMENT LTD. | 380,000 | $3,895,000 | 0.38% |
| Opaleye Management Inc. | 85,000 | $871,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 948,934 | $9,727,000 | 0.32% |
| EAM Investors, LLC | 261,161 | $2,677,000 | 0.31% |
| J. Goldman & Co LP | 405,000 | $4,151,000 | 0.25% |